Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07706179
What this trial is testing

Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer

Who this might be right for
HR+/HER2+ Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 10
Testing effectiveness (Phase 2)Study completedNCT03179904
What this trial is testing

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaHER2-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic 17
Early research (Phase 1)Ended earlyNCT03861403
What this trial is testing

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more
Leap Therapeutics, Inc. 10
Large-scale testing (Phase 3)UnknownNCT00688194
What this trial is testing

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 396
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Not applicableStudy completedNCT01411787
What this trial is testing

Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 11
Not applicableStudy completedNCT02652975
What this trial is testing

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

Who this might be right for
Breast NeoplasmsEndothelial DysfunctionCardiovascular Disease+1 more
University of Aarhus 76
Not applicableStudy completedNCT05690295
What this trial is testing

Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer

Who this might be right for
Breast Cancer SurvivorsPostmenopauseResistance Training
Universidad de La Frontera 26
Early research (Phase 1)Study completedNCT02300363
What this trial is testing

DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin

Who this might be right for
Healthy
Lexicon Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT04132960
What this trial is testing

Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis

Who this might be right for
Breast Tumors
UNICANCER 186
Not applicableStudy completedNCT05022823
What this trial is testing

Exercise and Compression for Lymphedema

Who this might be right for
Breast Cancer Related Lymphedema
AHS Cancer Control Alberta 40
Not applicableStudy completedNCT00428220
What this trial is testing

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more
Pfizer 223
Testing effectiveness (Phase 2)Study completedNCT01797120
What this trial is testing

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

Who this might be right for
Metastatic Breast Cancer
PrECOG, LLC. 131
Testing effectiveness (Phase 2)UnknownNCT04001621
What this trial is testing

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT02549430
What this trial is testing

To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

Who this might be right for
Breast Cancer
Fondazione Sandro Pitigliani 115
Not applicableEnded earlyNCT00869804
What this trial is testing

Heading Off Peripheral Neuropathy With Exercise

Who this might be right for
Peripheral Nervous System DisordersBreast NeoplasmsChemotherapy
University of Nebraska 19
Post-approval studies (Phase 4)Looking for participantsNCT06274515
What this trial is testing

Investigate Mechanisms of Resistance to Breast Cancer Therapies

Who this might be right for
Breast Cancer
Hoffmann-La Roche 320
Testing effectiveness (Phase 2)UnknownNCT00003253
What this trial is testing

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Oncotech 100
Not applicableLooking for participantsNCT06960720
What this trial is testing

Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

Who this might be right for
Breast CancerFatigue
West Virginia University 60
Large-scale testing (Phase 3)Study completedNCT00128310
What this trial is testing

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 252
Next Page